Women’s reproductive rights in the U.S. are narrowing. Meanwhile, 46% of all pregnancies in the U.S. are unintended, pointing to the stark evidence of the enduring need for access to effective, ...

“I’m seeing a trend among my younger patients, particularly Gen Z, of not using birth control because of misinformation they ...

WARREN, Mich., May 21, 2025 /PRNewswire/ -- FemCap (https://femcap.com), an FDA-approved, prescription-only contraceptive device, is offering a groundbreaking alternative in the world of birth control ...

SAN DIEGO--(BUSINESS WIRE)--2024 BIO International Convention—YourChoice Therapeutics, Inc., pioneering hormone-free family planning products, has completed its first-in-human clinical study for ...

Sebela’s Miudella is the first hormone-free IUD approved by the FDA in four decades and the first IUD to use nitinol.

There's more to life than the pill and the IUD, argues women's hormone expert Alisa Vitti—and she's got the intel you need to make the right choice for you. Eliminating hormonal birth control from ...

BERKELEY, Calif. -- A Berkeley startup says it's developing the first hormone-free birth control for both men and women. Researchers from UC Berkeley founded YourChoice Therapeutics. They say they ...

The double-blind, placebo-controlled, phase 1 study is evaluating the safety, tolerability, and pharmacokinetics of YCT-529 in 16 healthy male participants. YCT-529 is a retinoic acid receptor-alpha ...

The global hormonal contraceptives market is projected to grow from about $19.5 billion in 2017 to over $30 billion by 2026, according to a study by Transparency Market Research. If one considers the ...

A non-hormonal, reversible male contraceptive pill with very few side effects might not be as far off as previously thought, early human trial results suggest. In a first-in-human study, a drug called ...